12
Participants
Start Date
August 13, 2018
Primary Completion Date
January 25, 2022
Study Completion Date
January 25, 2022
Nivolumab
3mg/kg IV (or if prior alloHSCT, 1 mg/kg) over 30 minutes every 14 days on Days 1 and 15 for up to four 28-day courses.
Low dose Cyclophosphamide (CTX) Daily
Oral cyclophosphamide 50mg + nivolumab 3 mg/kg IV every 2 weeks for up to 4 courses of treatment
Low dose Cyclophosphamide (CTX) Every 7 Days
Oral cyclophosphamide 350 mg every 7 days + nivolumab 3mg/kg IV every 2 weeks for up to 4 courses of treatment
University of Minnesota Masonic Cancer Center, Minneapolis
Masonic Cancer Center, University of Minnesota
OTHER